NCI-1; october 23-24, 2019; DR. Delia tang; residence INN arlington capital view; total hotel cost complies with HHS policy on promoting efficient spending as of 1/3/2012
Ended Awarded Last action
- Contract number
- 75N91019F00133
- Awardee
-
B9 Select Resi VA Owner LLC UEI XKMGUUJD8P33
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $17,822
Award facts
- Contract value 100% obligated
- $17,822.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 721110 Hotels (except Casino Hotels) and Motels
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Arlington, VA 22202, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$5,035 | |
| Original award | $22,857 |
About this award
The National Cancer Institute (NCI) awarded a Blanket Purchase Agreement (BPA) call to B9 Select Resi VA Owner LLC, doing business as Residence Inn Arlington Capital View Hotel, for lodging and meeting space services in Arlington, Virginia. This firm fixed-price contract, valued at $17.8K, was awarded on October 22, 2019, and utilized for an NCI event held October 23-24, 2019 hosted by Dr. Delia Tang. The hotel accommodations complied with HHS policy on efficient spending as established January 3, 2012. No set-aside designation was applied to this award, indicating the contract was competed in full and open competition. The contract has an ultimate completion date of May 8, 2024.
B9 Select Resi VA Owner LLC is a subsidiary of Marriott International, Inc., and has been registered to receive federal contract awards since January 2011. As a Marriott-branded property, the hotel provides lodging and hospitality services supporting government agencies' conference, meeting, and official travel requirements in the Washington, D.C. metropolitan area. The National Institutes of Health, particularly the NCI and Center for Scientific Review, has awarded multiple contracts to this vendor for peer review meetings and related events, demonstrating the facility's established capability in supporting the agency's mission-critical gatherings.
Quick answers
Who was awarded contract 75N91019F00133?
75N91019F00133 was awarded to B9 Select Resi VA Owner LLC by National Cancer Institute (National Institutes of Health) on October 22, 2019.
How much is contract 75N91019F00133 worth?
The government has obligated $17,822 on 75N91019F00133.
Is contract 75N91019F00133 an order under another contract?
Yes. 75N91019F00133 is a BPA call under HHSN263201200009B, a blanket purchase agreement.
Was contract 75N91019F00133 competed?
The extent of competition for 75N91019F00133 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award